Blood PlateletsPlatelet AggregationLiver TransplantationTransplantation, HomologousKidney TransplantationPlatelet CountBone Marrow TransplantationPlatelet AdhesivenessHematopoietic Stem Cell TransplantationTransplantation, AutologousHeart TransplantationLung TransplantationPlatelet Membrane GlycoproteinsStem Cell TransplantationTransplantation ConditioningOrgan TransplantationPlatelet TransfusionGraft SurvivalPlatelet Factor 4Graft RejectionPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantationTransplantation ImmunologyPlatelet Activating FactorCell TransplantationPlatelet Glycoprotein GPIIb-IIIa ComplexPlatelet Function TestsTransplantation ChimeraPlatelet Glycoprotein GPIb-IX ComplexImmunosuppressive AgentsGraft vs Host DiseaseTreatment OutcomeTransplantation, IsogeneicThrombinLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationTime FactorsHeart-Lung TransplantationAdenosine DiphosphateAntigens, Human PlateletTissue and Organ ProcurementTransplantation ToleranceThrombocytopeniaRetrospective StudiesPeripheral Blood Stem Cell TransplantationHistocompatibility TestingLiver FailureImmunosuppressionFetal Tissue TransplantationPostoperative ComplicationsSkin TransplantationFibrinogenMegakaryocytesP-SelectinRecurrenceThrombosisTransplantation, HeterologousBleeding TimeWaiting ListsHematologic NeoplasmsMesenchymal Stem Cell TransplantationHistocompatibilityCorneal Transplantationvon Willebrand FactorWhole-Body IrradiationTacrolimusFollow-Up StudiesCyclosporineTissue TransplantationPlatelet Membrane Glycoprotein IIbSurvival AnalysisSurvival RateCadaverPlatelet Factor 3CollagenBrain Tissue TransplantationLiver DiseasesThromboxane A2Mice, Inbred C57BLFacial TransplantationDonor SelectionBusulfanAntibodies, MonoclonalOrgan PreservationAspirinHLA AntigensLeukemiaHemostasisBlood CoagulationSerotoninTransplantsRisk FactorsFlow CytometryKidney Failure, ChronicAcute DiseaseCombined Modality TherapyAnemia, Aplastic